Core Insights - Murphy Oil reported revenue of $665.71 million for Q1 2025, a year-over-year decline of 16.4% and a slight miss of 0.31% against the Zacks Consensus Estimate of $667.76 million [1] - The company's EPS for the same period was $0.56, down from $0.85 a year ago, but exceeded the consensus estimate of $0.48 by 16.67% [1] Financial Performance - Revenue from exploration and production in Canada was $165.70 million, surpassing the three-analyst average estimate of $158.14 million, reflecting a year-over-year increase of 21% [4] - Revenue from exploration and production in the United States was $509.50 million, compared to the average estimate of $494.29 million, showing a year-over-year decline of 22.8% [4] - Total revenue from sales to customers was $672.73 million, exceeding the three-analyst average estimate of $653.43 million, but representing a 15.4% decline compared to the previous year [4] Production Metrics - Total net crude oil and condensate production was 84.26 thousand barrels per day, below the estimated 85.84 thousand barrels per day [4] - Total net natural gas liquids production was 8.41 thousand barrels per day, compared to the estimated 9.16 thousand barrels per day [4] - Total net natural gas production was 424.23 million cubic feet per day, slightly below the estimated 426.47 million cubic feet per day [4] Stock Performance - Murphy Oil's shares returned +7% over the past month, while the Zacks S&P 500 composite increased by +10.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Permian Resources reported revenue of $1.38 billion for Q1 2025, reflecting a year-over-year increase of 10.7% [1] - The company's EPS remained stable at $0.42, matching the previous year's figure, but fell short of the consensus estimate of $0.44, resulting in an EPS surprise of -4.55% [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $1.39 billion, leading to a revenue surprise of -1.22% [1] Financial Performance Metrics - Average daily net production totaled 373,209 BOE/D, exceeding the six-analyst average estimate of 368,855 BOE/D [4] - Natural gas production averaged 673,388 Mcf/D, surpassing the five-analyst average estimate of 640,427.8 Mcf/D [4] - Oil production reached 174,967 BBL/D, which was above the five-analyst average estimate of 171,776 BBL/D [4] - Average sales price for oil, including derivative cash settlements, was $71.45, slightly below the four-analyst average estimate of $71.63 [4] - Net revenues from oil sales were reported at $1.11 billion, aligning with the two-analyst average estimate [4] Stock Performance - Shares of Permian Resources have increased by 15.5% over the past month, outperforming the Zacks S&P 500 composite's increase of 10.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - GoodRx Holdings, Inc. reported revenue of $202.97 million for Q1 2025, a year-over-year increase of 2.6% and an EPS of $0.09, compared to $0.08 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $202.59 million, resulting in a surprise of +0.19% [1] - The company did not deliver an EPS surprise, as the consensus EPS estimate was also $0.09 [1] Performance Metrics - GoodRx's shares returned +4.2% over the past month, while the Zacks S&P 500 composite increased by +10.6% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential outperformance against the broader market in the near term [3] Key Company Metrics - Monthly Active Consumers: 6 million, below the estimated 7 million [4] - Subscription plans: 680 thousand, slightly below the estimated 685 thousand [4] - Revenue from Prescription transactions: $148.92 million, exceeding the estimate of $146.53 million, representing a +2.4% year-over-year change [4] - Revenue from Other sources: $4.38 million, below the estimate of $5.47 million, reflecting a year-over-year decline of -18.5% [4] - Revenue from Pharma manufacturer solutions: $28.65 million, slightly below the estimate of $29.90 million, but showing a +16.9% year-over-year increase [4] - Revenue from Subscription: $21.02 million, above the estimate of $20.79 million, but down -7% year-over-year [4]

Core Insights - EPR Properties reported revenue of $146.36 million for the quarter ended March 2025, reflecting a year-over-year increase of 2.9% but a slight miss against the Zacks Consensus Estimate of $146.95 million, resulting in a revenue surprise of -0.40% [1] - The company's earnings per share (EPS) for the quarter was $1.21, significantly higher than the $0.75 reported in the same quarter last year, and exceeded the consensus estimate of $1.19 by 1.68% [1][4] - EPR Properties' stock has outperformed the Zacks S&P 500 composite, returning +15.3% over the past month compared to the composite's +10.6% [3] Revenue Breakdown - Rental revenue for EPR Properties was reported at $146.36 million, slightly below the average estimate of $146.95 million from three analysts, marking a year-over-year increase of 2.9% [4] - Mortgage and other financing income reached $17.04 million, surpassing the estimated $15.03 million by two analysts, and showing a significant year-over-year increase of 31.9% [4] - Other income was reported at $11.64 million, which fell short of the estimated $28.60 million from two analysts, representing a year-over-year decrease of 3.3% [4] - The diluted net earnings per share was $0.78, exceeding the average estimate of $0.63 from three analysts [4]

Core Viewpoint - MKS Instruments reported strong financial results for the quarter ended March 2025, with revenue and EPS exceeding both year-over-year figures and Wall Street expectations [1][3]. Financial Performance - Revenue for the quarter was $936 million, reflecting a year-over-year increase of 7.8% and a surprise of +0.27% over the Zacks Consensus Estimate of $933.5 million [1]. - EPS was reported at $1.71, compared to $1.18 in the same quarter last year, resulting in a surprise of +20.42% against the consensus estimate of $1.42 [1]. Segment Performance - Semiconductor segment revenues were $413 million, exceeding the average estimate of $403.45 million, with a year-over-year increase of 17.7% [4]. - Electronics and Packaging segment revenues reached $253 million, surpassing the average estimate of $242.64 million, marking a year-over-year growth of 21.6% [4]. - Specialty Industrial segment revenues were $270 million, slightly above the average estimate of $268.58 million, but showing a year-over-year decline of 12.6% [4]. - Total product revenues were $819 million, compared to the average estimate of $798.27 million, indicating an 8.6% year-over-year increase [4]. - Service revenues were $117 million, slightly below the average estimate of $118.75 million, with a year-over-year increase of 2.6% [4]. Stock Performance - MKS Instruments shares have returned +23.6% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change [3]. - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3].

Core Viewpoint - Waters Corporation reported strong first-quarter 2025 results, with non-GAAP earnings and net sales exceeding expectations, driven by robust demand across key sectors and regions [1][2][10]. Financial Performance - Non-GAAP earnings for Q1 2025 were $2.25 per share, surpassing the Zacks Consensus Estimate by 1.35% and increasing 1.8% year over year [1]. - Net sales reached $662 million, exceeding the Zacks Consensus Estimate by 1.08%, with a reported increase of 4% and a 7% increase on a constant currency basis year over year [1][11]. Segment Performance - The Waters segment accounted for 88.8% of net sales, generating $587.3 million, up 4.5% year over year and 8% at constant currency [3]. - The TA segment contributed $74.4 million (11.2% of net sales), reflecting a slight decline of 0.7% year over year but a 1% increase at constant currency [3]. Product and Service Breakdown - Instruments sales (39.7% of net sales) were $262.9 million, increasing 8.7% year over year and 11% at constant currency [4]. - Services sales (39.5% of net sales) totaled $261.2 million, with a modest increase of 0.2% year over year and 3% at constant currency [4]. - Chemistry sales (20.8% of net sales) reached $137.6 million, growing 2.6% year over year and 5% at constant currency [4]. Market Analysis - The Pharmaceutical market (59.1% of net sales) generated $391.1 million, up 4.5% year over year and 8% at constant currency [5]. - The Industrial market (27.5% of net sales) saw sales of $203.4 million, increasing 4.1% year over year and 6% at constant currency [5]. - The Government & Academic market (10.2% of net sales) generated $67.3 million, remaining flat year over year but increasing 3% at constant currency [6]. Geographic Performance - Asia (33.4% of net sales) generated $220.8 million, up 6.4% year over year and 13% at constant currency [6]. - Sales in the Americas (38.6% of net sales) were $255.5 million, increasing 6% year over year and at constant currency [6]. - Europe (28% of net sales) generated $185.4 million, decreasing 1.4% year over year but increasing 1% at constant currency [7]. Operating Details - Non-GAAP selling and administrative expenses were $170.1 million, up 6% year over year, expanding 50 basis points as a percentage of net sales [8]. - Research and development spending was $46 million, increasing 7.7% year over year, with a 20 basis point expansion as a percentage of net sales [8]. - The adjusted operating margin was 25.5%, contracting 150 basis points year over year [8]. Balance Sheet and Cash Flow - As of March 29, 2025, cash and cash equivalents were $382.9 million, up from $325.4 million as of December 31, 2024 [9]. - Cash generated from operations was $259.6 million, down from $262.9 million in the year-ago quarter [9]. - Free cash flow for Q1 2025 was $233.8 million [9]. Guidance - For Q2 2025, Waters expects non-GAAP earnings of $2.88-$2.98 per share, with a Zacks Consensus Estimate of $2.93 per share, indicating 11.4% growth year over year [10]. - Total sales growth is anticipated to be in the range of 4-6% on a reported basis, with constant currency sales growth expected to be between 5% and 7% [11][12].

Core Viewpoint - Serve Robotics is expected to report a significant decline in revenues for the first quarter of 2025, with a consensus estimate of $0.50 million, representing a 47.37% decrease compared to the same quarter last year [1] Financial Performance - In the fourth quarter of 2024, Serve Robotics reported revenues of $0.176 million, down from $0.43 million in the year-ago quarter, and incurred a loss of 23 cents per share, an improvement from a loss of 48 cents in the previous year [2] - The company missed the Zacks Consensus Estimate by 21.05% in the fourth quarter of 2024 [2] Operational Highlights - Delivery services revenues in the fourth quarter of 2024 were $0.93 million, up from $0.35 million year-over-year, with 57 daily active robots marking a 67.6% increase [3] - These robots generated an average of 455 daily supply hours, reflecting a 94% year-over-year increase [3] Growth Drivers - The momentum is expected to continue in the upcoming quarter due to improved utilization of the delivery fleet, expanded geographic reach, and operational efficiencies [4] - Serve Robotics has expanded its services to Los Angeles and Miami in 2024, reaching over 1,000 restaurants and 300,000 households [5] - The company has partnered with Shake Shack for robotic delivery and with Wing Aviation for multi-modal delivery services [5] Earnings Expectations - Serve Robotics currently has an Earnings ESP of 0.00% and a Zacks Rank of 3, indicating a neutral outlook for earnings performance [6]

Group 1 - Marathon Petroleum reported $31.85 billion in revenue for Q1 2025, a year-over-year decline of 4.1%, with an EPS of -$0.24 compared to $2.78 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $30.09 billion by 5.86%, and the EPS surprised positively by 61.90% against a consensus estimate of -$0.63 [1] - The stock has returned +21.9% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change, and currently holds a Zacks Rank 3 (Hold) [3] Group 2 - Net refinery throughput was 2,849 million barrels of oil per day, exceeding the average estimate of 2,765.67 million barrels by four analysts [4] - Crude oil refined was 2,623 million barrels of oil per day, surpassing the average estimate of 2,513.68 million barrels by three analysts [4] - Adjusted EBITDA for Refining & Marketing was $489 million, significantly higher than the average estimate of $286.27 million, while Midstream Adjusted EBITDA was $1.72 billion, slightly above the estimate of $1.68 billion [4]

For the quarter ended March 2025, Fiverr International (FVRR) reported revenue of $107.18 million, up 14.6% over the same period last year. EPS came in at $0.64, compared to $0.52 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $105.53 million, representing a surprise of +1.57%. The company delivered an EPS surprise of -4.48%, with the consensus EPS estimate being $0.67.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings - ...

Core Insights - Emerson Electric reported revenue of $4.43 billion for the quarter ended March 2025, a year-over-year increase of 1.3% and an EPS of $1.48, up from $1.36 a year ago, exceeding Zacks Consensus Estimates for both revenue and EPS [1] - The company’s stock has returned +13.9% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change, and currently holds a Zacks Rank 3 (Hold) [3] Financial Performance Metrics - Net Sales- Eliminations: -$18 million, better than the -$19.67 million average estimate, representing a +5.9% year-over-year change [4] - Net Sales- Software And Control- Total: $1.42 billion, exceeding the average estimate of $1.35 billion, with a year-over-year change of +6.7% [4] - Net Sales- Intelligent Devices- Total: $3.03 billion, slightly below the average estimate of $3.06 billion, showing a -1.1% year-over-year change [4] - Net Sales- Software and Control- Test & Measurement: $359 million, above the average estimate of $355.83 million, with a -2.2% year-over-year change [4] - Net Sales- Intelligent Devices- Safety & Productivity: $339 million, below the average estimate of $355.61 million, reflecting a -7.1% year-over-year change [4] - Net Sales- Intelligent Devices- Measurement & Analytical: $1 billion, below the average estimate of $1.02 billion, with a -1.1% year-over-year change [4] - Net Sales- Intelligent Devices- Final Control: $1.07 billion, matching the average estimate, with a +2.1% year-over-year change [4] - Net Sales- Intelligent Devices- Discrete Automation: $615 million, slightly above the average estimate of $610.20 million, showing a -2.7% year-over-year change [4] - EBIT- Intelligent Devices- Total: $725 million, below the average estimate of $746.93 million [4] - EBIT- Intelligent Devices- Measurement & Analytical: $266 million, below the average estimate of $275.70 million [4] - EBIT- Intelligent Devices- Discrete Automation: $117 million, slightly below the average estimate of $120.07 million [4] - EBIT- Software and Control- Test & Measurement: -$24 million, significantly below the average estimate of $133.64 million [4]